Laboratoire de Biophotonique et Pharmacologie
UMR CNRS 7213


Partenaires

CNRS
Logo Universite de strasbourg
 

Rechercher

Sur ce site

Sur le Web du CNRS


Accueil du site > Equipe Pharmacologie expérimentale > Publications

Publication 2017

4 avril 2017

M. ABBAS, L. JESEL, C. AUGER, L. AMOURA, N. MESSAS, G. MANIN, C. RUMIG, A.J. LEON-GONZALEZ, T.P. RIBEIRO, G.C. SILVA, R. ABOU-MERHI, E. HAMADE, M. HECKER, Y. GEORG, N. CHAKFE, P. OHLMANN, V.B. SCHINI-KERTH, F. TOTI & O. MOREL. Endothelial microparticles from acute coronary syndrome patients induce premature coronary artery endothelial cells ageing and thrombogenicity : role of the Ang II/AT1 receptor/NADPH oxidase-mediated activation of MAPKs and PI3-kinase pathways. Circulation 135, 280-296, 2017 IF 17.20 – EQ3

K. ELHABAZI, J.P. HUMBERT, I. BERTIN, R. QUILLET, V. UTARD, S. SCHNEIDER, M. SCHMITT, J.J. BOURGUIGNON, E. LABOUREYRAS, M. BEN BOUJEMA, G. SIMONNET, C. ANCEL, V. SIMONNEAUX, M. BELTRAMO, B. BUCHER, T. SORG, H. MEZIANE, E. SCHNEIDER, B. PETIT-DEMOULI, B. ILIEN, F. BIHEL & F. SIMONIN. RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents. Neuropharmacology 118, 188-198, 2017 IF 4.94 – EQ3